References
- Allen TM, Cullis PR. Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev, 2013;65:36–48
- Chakraborty S, Shukla D, Mishra B, Singh S. Lipid -- An emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm, 2009;73:1–15
- Dahan A, Hoffman A. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur J Pharm Biopharm, 2007;67:96–105
- Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm Res, 1996;13:1838–45
- Di L, Fish PV, Mano T. Bridging solubility between drug discovery and development. Drug Discov Today, 2012;17:486–95
- Feeney OM, Williams HD, Pouton CW, Porter CJ. ‘Stealth’ lipid-based formulations: Poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug. J Control Release, 2014;192C:219–27
- Gupta S. Biocompatible microemulsion systems for drug encapsulation and delivery. Curr Sci, 2011;101:174–88
- Han S-F, Yao T-T, Zhang X-X, Gan L, Zhu C, Yu H-Z, Gan Y. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: Effects of lipid composition and formulation. Int J Pharm, 2009;379:18–24
- Hippalgaonkar K, Majumdar S, Kansara V. Injectable lipid emulsions-advancements, opportunities and challenges. AAPS PharmSciTech, 2010;11:1526–40
- Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems -- A review (part 1). Trop J Pharm Res, 2013;12:255–64
- Hwang SJ, Park H, Park K. Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst, 1998;15:243–84
- Li Y, Li PK, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ. Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. Cancer Lett, 2014;349:8–14
- Lu Y, Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm, 2013;453:198–214
- Ma Q, Sun H, Che E, Zheng X, Jiang T, Sun C, Wang S. Uniform nano-sized valsartan for dissolution and bioavailability enhancement: Influence of particle size and crystalline state. Int J Pharm, 2013;441:75–81
- Mattheolabakis G, Rigas B, Constantinides PP. Nanodelivery strategies in cancer chemotherapy: Biological rationale and pharmaceutical perspectives. Nanomedicine, 2012;7:1577–90
- Perez-Vilar J, Hill RL. The structure and assembly of secreted mucins. J Biol Chem, 1999;274:31751–4
- Qi J, Lu Y, Wu W. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles. Curr Drug Metab, 2012;13:418–28
- Thanki K, Gangwal RP, Sangamwar AT, Jain S. Oral delivery of anticancer drugs: Challenges and opportunities. J Control Release, 2013;170:15–40
- Washington C. Stability of lipid emulsions for drug delivery. Adv Drug Del Rev, 1996;20:131–45
- Xu S, Olenyuk BZ, Okamoto CT, Hamm-Alvarez SF. Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances. Adv Drug Del Rev, 2013;65:121–38
- Ye Y, Zhang X, Zhang T, Wang H, Wu B. Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique. Drug Dev Ind Pharm, 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.954585
- Yuan H, Chen CY, Chai GH, Du YZ, Hu FQ. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol Pharm, 2013;10:1865–73
- Zabaleta V, Ponchel G, Salman H, Agueros M, Vauthier C, Irache JM. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study. Eur J Pharm Biopharm, 2012;81:514–23
- Zhang X, Zhang T, Zhou X, Liu H, Sun H, Ma Z, Wu B. Enhancement of oral bioavailability of tripterine through lipid nanospheres: Preparation, characterization, and absorption evaluation. J Pharm Sci, 2014;103:1711–19